Sort
25,944 grants matching “neurodegeneration”
Sex-Specific Genetic Drivers of Alzheimer's Disease Endophenotypes
$830,859Logan C Dumitrescu · Vanderbilt University Medical Center · R01 · FY2022 · AG
Impact of neuromelanin and Tau accumulation during aging and disease on local gene expression in the human locus coeruleus using spatially-resolved transcriptomics with protein detection
$830,805Keri Martinowich · Lieber Institute, Inc. · R01 · FY2025 · AG
Characterization of relationship between tau pathology and neurodegeneration in Alzheimer's disease using multimodal imaging
$830,743Sandhitsu Das · University Of Pennsylvania · R01 · FY2022 · AG
The role of peripheral myeloid cells in Alzheimers disease
$830,565Towfique Raj · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Roles of Cdk5 in neurodevelopment and neurodegeneration
$830,451Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Role of a novel risk loci HAVCR2 of late-onset Alzheimer's disease in the regulation of microglial response in neurodegeneration
$829,912Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2024 · AG
Common mechanistic biomarkers of vascular and neuro-degeneration
$829,329Yongmei Liu · Duke University · R01 · FY2023 · AG
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease
$829,047Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimerâs disease
$828,613Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2017 · AG
Stress, Weathering, and Blood-Based Biomarkers of Alzheimerâs Disease
$828,609Steven R Beach · University Of Georgia · R01 · FY2025 · AG
Neuroimmune Genomic Profiling of Alzheimer's Disease
$828,534Evgeny I Rogaev · Univ Of Massachusetts Med Sch Worcester · U01 · FY2024 · AG
Presenilin and APP in the Brain
$828,365Jie Shen · Brigham And Women'S Hospital · R01 · FY2025 · NS
Presenilin and APP in the Brain
$828,365Jie Shen · Brigham And Women'S Hospital · R01 · FY2024 · NS
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD
$828,275Kyrana Tsapkini · Johns Hopkins University · R01 · FY2022 · AG
Alzheimer's Abeta, Tau, Apolipoproteins and Blood-brain barrier
$828,100Berislav V Zlokovic · University Of Southern California · R01 · FY2020 · NS
Disordered Cellular Cholesterol Movement, Cell Death, and Multisystem Disease
$827,892Stephen Dean Turley · Ut Southwestern Medical Center · R01 · FY2013 · HL
Molecular and Cellular Pathways Regulating Neurovascular Dysfunction in Degenerative Tauopathies
$827,748Lee E Goldstein · Boston University Medical Campus · R56 · FY2020 · AG
CSF Clearance in Sporadic Alzheimer's Disease
$827,746Yi Li · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AG
Routes to Enhanced HIV Neuropathogenesis Through Expression of Subclinical Levels of Endogenous Amyloid-Beta
$827,685David J Volsky · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS
Sleep Quality and Mechanistic Links to Alzheimer Disease and Related Disorders among older Mexican Americans and Non-Hispanic Whites
$827,604Kristine Yaffe · University Of California, San Francisco · R01 · FY2019 · AG
TSE Prion Cell Biology
$827,504Gerald Baron · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Hypothalamic AgRP neurons are determinants of healthy lifespan and higher brain f
$827,500Tamas L Horvath · Yale University · DP1 · FY2010 · OD
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$827,161Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Core B: The Clinical and Translational Research Core
$826,966Xue K Zhong · Cleveland Clinic Foundation · P20 · FY2018 · GM
Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease
$826,900Hyun Kyu Lee · Posit Science Corporation · R44 · FY2025 · AG